A phase II study for metabolicin vivoresponse monitoring...

BMC Cancer 2012 / 12 Vol. 12; Iss. 1

A phase II study for metabolicin vivoresponse monitoring with sequential18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial

Anne Katrin Berger, Carl von Gall, Ulrich Abel, Stefan Delorme, Matthias Kloor, Jennifer Ose, Tim Frederik Weber, Annika Stange, Georg Martin Haag, Uwe Haberkorn, Florian Lordick, Dirk Jäger
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
DOI:
10.1186/1471-2407-12-108
Date:
December, 2012
File:
PDF, 152 KB
english, 2012
Conversion to is in progress
Conversion to is failed